Clinical Trials Directory

Trials / Unknown

UnknownNCT05193747

The Depth of Paediatric Anaesthesia: Observational Trial

Status
Unknown
Phase
Study type
Observational
Enrollment
100 (estimated)
Sponsor
Brno University Hospital · Academic / Other
Sex
All
Age
1 Year – 18 Years
Healthy volunteers

Summary

Perioperative measurement of the Depth of anaesthesia is currently recommended part of daily anaesthesia good clinical practice. The optimal depth of anaesthesia measured by Bispectral index could be between 40-60. The lower (over 60) depth of anaesthesia could be associated with accidental intraoperative episodes of awareness and deeper (below 40) anaesthesia could lead to higher adverse events or even haemodynamic instability.

Detailed description

The hypothesis of the trial is that during the perioperative period serious fluctuations outside the recommended target depth of anaesthesia could occur. These fluctuations and the cumulative time spent in the shallow (over 60 BIS) or deep (under 40 BIS) could be associated with postoperative complications like emergence delirium (PAED over 10, and PAED over 12- 2 measurement methods), postoperative nausea and vomiting (PONV) and other postoperative complications (respiratory, hemodynamic). Paediatric patients (between 1 year -19 years) undergoing elective general anaesthesia with presumed duration over 1 hour will be eligible for inclusion. The patients will be screened for eligibility during the preanaesthesia visit in the anaesthesiology examination room. After the Ethics committee and registration of the study at clinicaltrials.gov, the patients will be enrolled - according to the trial design. There is a presumption that informed consent won't be needed for participation due to observational trial. The anaesthesia induction will be performed either inhalation or intravenous route. After anaesthesia induction BIS monitor will be placed on the forehead according to the manufacturer recommendation and the anaesthesia team will be blinded to BIS monitor during the whole case. The initial BIS tracing will be recorded starting the surgery initiation (defined as the depth of anesthesia by the anaesthesiologist to initiate surgical intervention) and ending with end of surgical intervention. The incidence of periods outside the recommended anaesthesia depth will be recorded (episode is defined by ≥ 30 seconds interval outside the predefined limits, the end of episode is defined by the return to recommended BIS level). The cumulative time spent outside the recommended BIS levels will be evaluated as the primary outcome measure. The anaesthesiologist's ability to respond to fluctuations defined as YES / NO response, type of intervention and latency of the anaesthesiologist's response to fluctuation will be evaluated. The BIS recording will be terminated at the time the surgical intervention is finished. After surgery/anaesthesia, the patient will be transferred to ICU or post-anaesthesia care unit (PACU), where the incidence of emergence delirium (defined by PEAD score over 10 and over 12 - according to 2 measurement methods) and the incidence of PONV will be recorded. Also, cumulative incidence of overall complication in the postoperative period (desaturation, the need for oxygen therapy, haemodynamic instability, arrhythmias (over 150/min, below 50/min, allergic reactions) will be recorded. In the case of a critical BIS value (≥90, ≤10), blinding will be interrupted due to patient safety and the value will be notified to the anesthesiology team and the event will be recorded as a critical event.

Conditions

Interventions

TypeNameDescription
OTHERAnesthesia depth monitoringBIS monitor will be placed on the forehead according to the manufacturer recommendation and the anaesthesia team will be blinded to BIS monitor during the whole case. The initial BIS tracing will be recorded starting the surgery initiation (defined as the depth of anesthesia by the anaesthesiologist to initiate surgical intervention) and ending with end of surgical intervention.

Timeline

Start date
2022-01-14
Primary completion
2023-12-31
Completion
2023-12-31
First posted
2022-01-18
Last updated
2023-03-24

Locations

1 site across 1 country: Czechia

Source: ClinicalTrials.gov record NCT05193747. Inclusion in this directory is not an endorsement.